PCM
AEHR icon

Prelude Capital Management’s Aehr Test Systems AEHR Stock Holding History

Prelude Capital Management’s Portfolio AEHR Stock Details AEHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,000
Closed -$183K – 1157
2024
Q4 		$183K Hold
11,000
– – 0.01% 1016
2024
Q3 		$141K Hold
11,000
– – 0.01% 1120
2024
Q2 		$123K Sell
11,000
-11,000
-50% -$128K 0.01% 1078
2024
Q1 		$273K Buy
22,000
+12,113
+123% +$202K 0.01% 947
2023
Q4 		$262K Buy
+9,887
New +$288K 0.02% 804

Other funds holding AEHR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HFF
Halter Ferguson Financial Carmel, Indiana $456M AUM 49.85% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Prelude Capital Management's AEHR Position: Q1 2025 in Review

Prelude Capital Management sold out of Aehr Test Systems (AEHR) in Q1 2025, closing a stake of 11,000 shares — an estimated $183K sold.

Prelude Capital Management first reported a position in AEHR in Q4 2023 and held it in 5 quarters. The position peaked at $273K in Q1 2024. 115 funds tracked by Wall St. Rank hold AEHR as of Q1 2025.

  • Prelude Capital Management reported no remaining Aehr Test Systems position as of Q1 2025 after selling out during the quarter.
  • Prelude Capital Management sold 11,000 Aehr Test Systems shares in Q1 2025, an estimated $183K.
  • Prelude Capital Management first reported a position in Aehr Test Systems in Q4 2023 and held it in 5 quarters.
  • Prelude Capital Management's Aehr Test Systems position peaked at $273K in Q1 2024.
  • 115 funds tracked by Wall St. Rank held Aehr Test Systems as of Q1 2025.

Based on Prelude Capital Management's 13F filing for Q1 2025, filed 15 May 2025.